Literature DB >> 19929882

Nontuberculous mycobacterial pulmonary infection in renal transplant recipients.

T A Ho1, M Rommelaere, E Coche, J-C Yombi, N Kanaan.   

Abstract

The most common presentations of nontuberculous mycobacterial infections in kidney transplant recipients (KTR) are cutaneous and disseminated diseases. Pleuropulmonary infection not associated with disseminated disease is rare. Its diagnosis can be difficult, requiring a combination of clinical, radiological, and bacteriological criteria. We report on a Mycobacterium avium complex pulmonary infection in a KTR with underlying chronic obstructive pulmonary disease. Chest computed tomography showed an excavated lesion of the right upper lobe, similar to a typical lesion of pulmonary tuberculosis. Evolution was favorable with multiple-drug therapy including rifampicin, ethambutol, and clarithromycin, along with a slight reduction in immunosuppression. We review the literature and discuss the epidemiology, diagnosis, management, and follow-up of this uncommon post-transplant complication.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19929882     DOI: 10.1111/j.1399-3062.2009.00473.x

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  3 in total

1.  Successful Diagnosis of Intestinal Mycobacterium avium Complex Infection in a Kidney Transplant Recipient Using Nasogastric Aspirate Culture: A Case Report.

Authors:  J B Parr; A M Lachiewicz; D van Duin; P P Chong
Journal:  Transplant Proc       Date:  2017-12       Impact factor: 1.066

Review 2.  Extensor Tenosynovitis due to Mycobacterium marseillense Infection in a Renal Transplant Recipient.

Authors:  Takashi Hirase; Jessica T Le; Robert A Jack; Todd E Siff; Shari R Liberman
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2021-01-12

Review 3.  '"Why me, why now?" Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection.

Authors:  M Alexandra Lake; Lyn R Ambrose; Marc C I Lipman; David M Lowe
Journal:  BMC Med       Date:  2016-03-23       Impact factor: 8.775

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.